Silverarc Capital Management, LLC Alpine Immune Sciences, Inc. Transaction History
Silverarc Capital Management, LLC
- $298 Million
- Q1 2024
A detailed history of Silverarc Capital Management, LLC transactions in Alpine Immune Sciences, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 199,020 shares of ALPN stock, worth $0. This represents 2.65% of its overall portfolio holdings.
Number of Shares
199,020
Previous 297,789
33.17%
Holding current value
$0
Previous $5.68 Million
39.01%
% of portfolio
2.65%
Previous 1.79%
Shares
2 transactions
Others Institutions Holding ALPN
# of Institutions
186Shares Held
62MCall Options Held
158KPut Options Held
199K-
Decheng Capital LLC Menlo Park, CA8.32MShares$044.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.78MShares$02.76% of portfolio
-
Black Rock Inc. New York, NY3.58MShares$00.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.13MShares$06.52% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.08MShares$00.01% of portfolio
About ALPINE IMMUNE SCIENCES, INC.
- Ticker ALPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,006,700
- Description
- Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...